Codeine and Scan abnormal - a phase IV clinical study of FDA data
Summary:
We study 42,768 people who take Codeine (codeine sulfate) or have Scan abnormal. No report of Scan abnormal is found in people who take Codeine.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
What is Codeine?
Codeine has active ingredients of codeine sulfate. It is often used in pain. eHealthMe is studying from 42,342 Codeine users. Check the latest studies of Codeine.
What is Scan Abnormal?
Scan abnormal is found to be associated with 113 drugs and 100 conditions by eHealthMe. Check the latest studies of Scan abnormal.
No report is found.
Do you take Codeine and have Scan abnormal?
- Check whether Scan abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Codeine:
- Codeine (42,342 reports)
Scan abnormal treatments and more:
- Scan abnormal (426 reports)
How severe was Scan abnormal and when was it recovered:
Expand to all the drugs that have ingredients of codeine sulfate:
Browse all side effects of Codeine:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Scan abnormal:
Browse all the conditions that are associated with Scan abnormal:
How the study uses the data?
The study uses data from the FDA. It is based on codeine sulfate (the active ingredients of Codeine) and Codeine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Amoxicillin cause Skin Disorder? - 13 seconds ago
- Multiple Sclerosis Aggravated and Wolff-Parkinson-White Syndrome - 16 seconds ago
- Could Basaglar cause Nightmares? - 32 seconds ago
- Gastric Ph Decreased and Fever - 34 seconds ago
- Celebrex vs. Ketoprofen, side effect and effectiveness comparison - 34 seconds ago
- How effective is Iodine for Hypothyroidism? - 34 seconds ago
- Could Xanax cause Wegener'S Granulomatosis? - 34 seconds ago
- Maxzide vs. Hydralazine And Hydrochlorthiazide, side effect and effectiveness comparison - 49 seconds ago
- Bronchopulmonary Aspergillosis and Hair Loss - 51 seconds ago
- Wellbutrin Sr vs. Remeron, side effect and effectiveness comparison - 53 seconds ago